Biomedical Engineering Reference
In-Depth Information
48. Swarbrick, J.; Boylan, J.
Encyclopedia of Pharmaceutical Technology
; 2nd ed.; MArcel
Dekker: New York, 2002.
49. Panyam, J.; Labhasetwar, V. Biodegradable Nanoparticles for Drug and Gene Delivery to
Cells and Tissue.
Adv. Drug Deliv. Rev.
2003,
55,
329-347.
50. Kroll, R. A.; Pagel, M. A.; Muldoon, L. L.; Roman-Goldstein, S.; Fiamengo, S. A.; Neuwelt,
E. A. Improving Drug Delivery to Intracerebral Tumor and Surrounding Brain in a Rodent
Model: A Comparison of Osmotic versus Bradykinin Modification of the Blood-Brain and/or
Blood-Tumor Barriers.
Neurosurgery
1998,
43,
879-886.
51. Kreuter, J.; Ramge, P.; Petrov, V.; Hamm, S.; Gelperina, S. E.; Engelhardt, B.;
Alyautdin, R.; von Briesen, H.; Begley, D. J. Direct Evidence That Polysorbate-80-Coated
Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms
Requiring Prior Binding of Drug to the Nanoparticles.
Pharm. Res.
2003,
20,
409-416.
52. Zauner, W.; Farrow, N. A.; Haines, A. M. In Vitro Uptake of Polystyrene Microspheres: Effect
of Particle Size, Cell Line and Cell Density.
J. Contr. Release
2001,
71,
39-51.
53. Redhead, H. M.; Davis, S. S.; Illum, L. Drug Delivery in Poly(lactide-co-glycolide) Nanopar-
ticles Surface Modified with Poloxamer 407 and Poloxamine 908: In Vitro Characterisation
and In Vivo Evaluation.
J. Contr. Release
2001,
70,
353-363.
54. Govender, T.; Stolnik, S.; Garnett, M. C.; Illum, L.; Davis, S. S. PLGA Nanoparticles Prepared
by Nanoprecipitation: Drug Loading and Release Studies of a Water Soluble Drug.
J. Contr.
Release
1999,
57,
171-185.
55. Yang, L.; Cao, Z.; Sajja, H.; Mao, H.; Wang, L.; Geng, H.; Xu, H.; Jiang, T.; Wood, W.; Nie,
S.; Wang, A. Development of Receptor Targeted Iron Oxide Nanoparticles for Efficient Drug
Delivery and Tumor Imaging.
J. Biomed. Nanotech.
2008,
4,
1-11.
56. Yang, L.; Peng, X.; Wang, Y.; Wang, X.; Cao, Z.; Ni, C.; Karna, P.; Zhang, X.; Wood, W.; Gao,
X.; Nie, S.; Mao, H. Receptor-Targeted Nanoparticles for In Vivo Imaging of Breast Cancer.
Clin. Cancer Res.
2009,
15,
4722-4732.
57. Aguilar, Z.; Aguilar, Y.; Xu, H.; Jones, B.; Dixon, J.; Xu, H.; Wang, A. Nanomaterials in Medi-
cine.
Electrochem. Soc. Trans.
2010,
33,
69-74.
58. Govender, T.; Riley, T.; Ehtezazi, T.; Garnett, M. C.; Stolnik, S.; Illum, L.; Davis, S. S. Defin-
ing the Drug Incorporation Properties of PLA-PEG Nanoparticles.
Int. J. Pharm.
2000,
199,
95-110.
59. Panyam, J.; Williams, D.; Dash, A.; Leslie-Pelecky, D.; Labhasetwar, V. Solid-State Solubility
Influences Encapsulation and Release of Hydrophobic Drugs from PLGA/PLA Nanoparticles.
J. Pharm. Sci.
2004,
93,
1804-1814.
60. Peracchia, M. T.; Gref, R.; Minamitae, Y.; Domb, A.; Lotan, N.; Langer, R. PEG-Coated
Nanospheres from Amphiphilic Diblock and Multiblock Copolymers: Investigation of Their
Drug Encapsulation and Release Characteristics.
J. Contr. Release
1997,
46,
223-231.
61. Calvo, P.; Remuñan-López, C.; Vila-Jato, J. L.; Alonso, M. J. Chitosan and Chitosan/Ethylene
Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and
Vaccines.
Pharm. Res.
1997,
14,
1431-1436.
62. Chen, Y.; McCulloch, R. K.; Gray, B. N. Synthesis of Albumin-Dextran Sulfate Microspheres
Possessing Favourable Loading and Release Characteristics for the Anticancer Drug Doxoru-
bicin.
J. Contr. Release
1994,
31,
49-54.
63. Chen, Y.; Mohanraj, V.; Parkin, J. Chitosan-Dextran Sulfate Nanoparticles for Delivery of an
Anti-angiogenesis Peptide.
Int. J. Pept. Res. Ther.
2003,
10,
621-629.
64. Westesen, K.; Bunjes, H.; Koch, M. H. J. Physicochemical Characterization of Lipid Nanopar-
ticles and Evaluation of Their Drug Loading Capacity and Sustained Release Potential.
J. Controlled Release
1997,
48,
223-236.
